Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ingevity Corp Regulatory Filings 2021

Feb 17, 2021

31679_rns_2021-02-17_0024acf4-ee93-4f17-8766-91f6d7a576ff.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

February 15, 2021

Date of Report (date of earliest event reported)


INGEVITY CORPORATION

(Exact name of registrant as specified in its charter)


Delaware 001-37586 47-4027764
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.)
4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405
(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: 843 - 740-2300

Not Applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: — Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock ($0.01 par value) NGVT New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o

ITEM 8.01 OTHER INFORMATION.

On February 15, 2021, Ingevity Corporation (the “Company”) issued a press release regarding the passing of the Chairman of the Board Rick Kelson, a copy of which is filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.

On February 17, 2021, the Company announced that the Board appointed Jean S. Blackwell to serve as Chair of the Board, effective immediately. A copy of the press release is filed as Exhibit 99.2 to this current report on Form 8-K and is incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

Exhibit No. Description of Exhibit
99.1 Press release dated February 15, 2021.
99.2 Press release dated February 17, 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INGEVITY CORPORATION
(Registrant)
By: /S/ JOHN C. FORTSON
John C. Fortson
President and Chief Executive Officer

Date: February 17, 2021